Publicaciones en las que colabora con Sergio Raposeiras Roubín (26)

2024

  1. Artificial intelligence-derived risk score for mortality in secondary mitral regurgitation treated by transcatheter edge-to-edge repair: The EuroSMR risk score

    European Heart Journal, Vol. 45, Núm. 11, pp. 922-936

  2. Prevalence and prognostic significance of malnutrition in patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge repair

    Catheterization and Cardiovascular Interventions, Vol. 104, Núm. 2, pp. 390-400

2022

  1. A Score to Assess Mortality After Percutaneous Mitral Valve Repair

    Journal of the American College of Cardiology, Vol. 79, Núm. 6, pp. 562-573

  2. Applicability of the Academic Research Consortium for High Bleeding Risk in acute coronary syndrome undergoing percutaneous coronary intervention

    Revista Espanola de Cardiologia, Vol. 75, Núm. 5, pp. 375-383

  3. Cierre de orejuela izquierda frente a ACOD en pacientes mayores: análisis con emparejamiento por puntuación de propensión

    REC: Interventional Cardiology, Vol. 4, Núm. 4, pp. 304-310

  4. Evolution of tricuspid regurgitation after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation and its impact on mortality

    European Journal of Heart Failure, Vol. 24, Núm. 11, pp. 2175-2184

  5. Prognostic Impact of Nutritional Status After Transcatheter Edge-to-Edge Mitral Valve Repair: The MIVNUT Registry

    Journal of the American Heart Association, Vol. 11, Núm. 20

2021

  1. Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets

    The Lancet, Vol. 397, Núm. 10270, pp. 199-207

2020

  1. Impact of anticoagulation in patients with dementia and atrial fibrillation. Results of the CardioCHUVI-FA registry

    Revista Espanola de Cardiologia, Vol. 73, Núm. 11, pp. 877-884

  2. Impact of malnutrition in the embolic-haemorrhagic trade-off of elderly patients with atrial fibrillation

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Vol. 22, Núm. 6, pp. 878-887

  3. Impact of renin-angiotensin system blockade on the prognosis of acute coronary syndrome based on left ventricular ejection fraction

    Revista espanola de cardiologia (English ed.), Vol. 73, Núm. 2, pp. 114-122

  4. Incidence, predictors and prognostic impact of intracranial bleeding within the first year after an acute coronary syndrome in patients treated with percutaneous coronary intervention

    European Heart Journal: Acute Cardiovascular Care, Vol. 9, Núm. 7, pp. 764-770

  5. P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects

    European heart journal. Cardiovascular pharmacotherapy, Vol. 6, Núm. 1, pp. 31-42

  6. Usefulness of Bleeding After Acute Coronary Syndromes for Unmasking Silent Cancer

    American Journal of Cardiology, Vol. 125, Núm. 12, pp. 1801-1808

  7. Vitamin K Antagonists and Direct Oral Anticoagulants in Nonagenarian Patients With Atrial Fibrillation

    Journal of the American Medical Directors Association, Vol. 21, Núm. 3, pp. 367-373.e1

2019

  1. Annual Incidence of Confirmed Stent Thrombosis and Clinical Predictors in Patients With ACS Treated With Ticagrelor or Prasugrel

    Revista Espanola de Cardiologia, Vol. 72, Núm. 4, pp. 298-304

  2. Prasugrel or ticagrelor in patients with acute coronary syndrome and diabetes: a propensity matched substudy of RENAMI

    European Heart Journal: Acute Cardiovascular Care, Vol. 8, Núm. 6, pp. 536-542

  3. Renin–Angiotensin System Blockade and Risk of Heart Failure After Myocardial Infarction Based on Left Ventricular Ejection Fraction: A Retrospective Cohort Study

    American Journal of Cardiovascular Drugs, Vol. 19, Núm. 5, pp. 487-495

  4. Risk of cancer after an acute coronary syndrome according to the type of P2Y12 inhibitor

    Thrombosis Research, Vol. 174, pp. 51-58

  5. Usefulness of the PARIS Score to Evaluate the Ischemic-hemorrhagic Net Benefit With Ticagrelor and Prasugrel After an Acute Coronary Syndrome

    Revista Espanola de Cardiologia, Vol. 72, Núm. 3, pp. 215-223